FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,475 | -29.0% | 1,295 | 0.0% | 0.00% | – |
| Q2 2023 | $9,117 | -0.7% | 1,295 | -10.0% | 0.00% | – |
| Q4 2022 | $9,181 | -33.9% | 1,439 | -11.2% | 0.00% | -100.0% |
| Q3 2022 | $13,900 | -36.9% | 1,620 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $22,032 | -10.7% | 1,620 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $24,673 | -83.6% | 1,620 | -75.3% | 0.00% | -50.0% |
| Q4 2021 | $150,233 | +64.2% | 6,569 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $91,506 | – | 6,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $25,566,000 | 5.41% |
| Flagship Pioneering Inc. | 12,674,120 | $256,905,000 | 4.68% |
| Birchview Capital, LP | 314,143 | $6,368,000 | 3.67% |
| Monashee Investment Management LLC | 560,360 | $11,359,000 | 1.50% |
| Artal Group S.A. | 1,720,720 | $34,879,000 | 0.75% |
| Alphabet Inc. | 500,901 | $10,153,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,270,000 | 0.48% |
| Casdin Capital, LLC | 216,216 | $4,383,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 258,700 | $5,244,000 | 0.08% |
| Woodline Partners LP | 103,040 | $2,089,000 | 0.06% |